Lenacapavir: Revolutionary HIV Prevention Drug Named 2024 Breakthrough of the Year
Science Magazine named lenacapavir its 2024 Breakthrough of the Year. In clinical trials, the twice-yearly injection provided complete protection against HIV infection — none of the 2,134 women who received the drug in the PURPOSE 1 trial contracted the virus.
The drug works through a novel mechanism, targeting multiple stages of the HIV life cycle simultaneously. Unlike daily pills, the long-acting injection only needs to be administered every six months, dramatically improving adherence.
“In clinical trials, the twice-yearly injection provided complete protection against HIV infection — none of the 2,134 women who received the drug in the PURPOSE 1 trial contracted the virus.”
"This could be transformative for HIV prevention," said Dr. Anthony Fauci. The breakthrough offers hope that the decades-long AIDS epidemic could finally be brought under control, especially in regions where daily medication regimens are challenging to maintain.
How did this story make you feel?
📎 Cite this article
Good News Good Vibes. (2024, December 19). Lenacapavir: Revolutionary HIV Prevention Drug Named 2024 Breakthrough of the Year. Retrieved from https://goodnewsgoodvibes.com/en/article/lenacapavir-hiv-prevention-breakthrough-2024
https://goodnewsgoodvibes.com/en/article/lenacapavir-hiv-prevention-breakthrough-2024
Editorial Team
Our editorial team curates and verifies positive news from credible sources worldwide.
Last reviewed: March 21, 2026
Trending
A Tiny Device Brings Quantum Entanglement to Room Temperature
Science · 5 min
A Louisville Restaurant Gives Away 100% of Its Profits — and Topped $100,000 in Year One
Community · 4 min
Oregon Zoo Sets a Record With 15 California Condor Chicks in One Year
Animals · 5 min
Europe Tears Down a Record 603 River Barriers, Setting Its Waters Free
Environment · 5 min
DeepMind unveils Co-Scientist, an AI research partner that already helped find a liver-disease drug candidate
Artificial Intelligence · 5 min
